Gynecomastia Surgery — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Gynecomastia surgery (reduction mastoplasty or mastectomy for gynecomastia) corrects the abnormal enlargement of male breast tissue — a condition estimated to affect 32–65% of males at some life stage. True gynecomastia involves proliferation of the glandular breast disc behind the nipple-areola complex, distinguishable from pseudo-gynecomastia (fatty breast enlargement without glandular hypertrophy). Surgical correction depends on the ratio of glandular tissue to fat and the degree of skin excess. Grade I (minor) and Grade II (moderate) gynecomastia without significant ptosis is treated with sub-areolar disc excision combined with power-assisted liposuction for optimal contouring. Grade III (moderate) with minor ptosis may require skin excision via an intra-areolar or periareolar approach. Grade IV (severe with significant ptosis) requires skin reduction with nipple repositioning, similar to female breast reduction. Surgery achieves permanent correction when the underlying hormonal or pharmacological cause is addressed. Gynecomastia surgery is one of the top five cosmetic procedures performed in men globally, with the American Society of Plastic Surgeons reporting over 26,000 procedures annually in the United States alone. Gynecomastia surgery is performed by plastic surgeons and breast surgeons trained in male chest contouring.

Surgical correction of gynecomastia is indicated for males with persistent, symptomatic, or cosmetically distressing breast enlargement that has failed to resolve spontaneously or with medical management. Before surgery, pathological causes must be excluded: hypogonadism (low testosterone), hyperprolactinaemia, liver disease (cirrhosis causing oestrogen excess), thyroid disorders, and rare adrenal or testicular hormone-secreting tumours. Drug-induced gynecomastia — from anabolic steroids, cannabis, spironolactone, anti-androgens (bicalutamide, finasteride), SSRIs, omeprazole, and certain cardiovascular drugs — may regress if the offending agent is withdrawn within 12 months; beyond this point, fibrous glandular tissue is established and surgery is the definitive treatment. Pubertal gynecomastia in adolescents (peak incidence 13–14 years) resolves spontaneously in 75% within 2 years and observation is first-line management; surgery is deferred until after puberty. Adult males with gynecomastia present for over 12 months, significant psychological distress, social avoidance, inability to exercise or swim, or physical discomfort are appropriate surgical candidates provided pre-operative hormonal assessment is complete.

Pre-operative assessment includes breast examination, ultrasound to characterise glandular versus fatty tissue and exclude rare breast malignancy, and hormonal blood tests. Surgery is typically performed under general anaesthesia as a day case, though local anaesthesia with intravenous sedation is an option for Grade I–II cases. Power-assisted liposuction is performed first through a small access incision at the lateral chest wall (3–4 mm stab incision), de-fatting the breast and peripheral chest to create an even platform for gland excision. The fibroglandular disc — a firm, rubbery structure immediately posterior to the nipple-areola complex — is then removed through a semicircular incision along the inferior areolar border (Webster incision at the 4–8 o'clock position). The gland is excised in one piece using sharp dissection with scissors and electrocautery, leaving a thin layer of breast tissue immediately beneath the areola to prevent areolar hollowing or inversion. Haemostasis is meticulous. A small suction drain is often placed through the existing liposuction incision. A compression vest is applied immediately post-operatively. For Grade III–IV gynecomastia with skin excess, a Wise pattern or circumareolar skin excision is planned pre-operatively. All excised tissue is sent for histological examination to exclude breast carcinoma. Total operative time is typically 1.5–3 hours under general anaesthesia.

Gynecomastia surgery achieves excellent cosmetic and functional outcomes in over 90% of patients. Patient satisfaction rates are consistently high in published series, with most men experiencing significant improvement in self-confidence, ability to exercise and swim, and quality of life. The combination of liposuction and glandular excision provides superior aesthetic contouring compared to either technique alone for true gynecomastia. Results are permanent in the vast majority — providing the underlying cause (anabolic steroids, offending medication) is discontinued, recurrence is rare below 5%. Histological analysis of excised tissue identifies occult breast carcinoma in approximately 0.5–1% of cases, representing an important diagnostic benefit of surgical excision over liposuction-only approaches. Scarring along the inferior areolar border is typically well-concealed at the colour transition boundary and fades over 12–18 months with appropriate scar management. Body dysmorphic disorder (BDD) must be screened pre-operatively as these patients may not achieve subjective satisfaction despite objectively excellent outcomes.

Gynecomastia surgery is generally safe with a low serious complication rate. Haematoma (blood collection beneath the skin) occurs in 2–3% of cases, typically within 24 hours of surgery, and may require return to theatre for drainage if significant. Seroma (fluid collection) occurs in up to 5% and is managed by aspiration in clinic. Surgical site infection is uncommon (under 1%) with prophylactic antibiotics. Nipple sensory changes — numbness, hypersensitivity, or altered sensation — are very common (50–80%) in the short term and usually improve over 3–6 months; permanent sensory change affects approximately 5%. Contour irregularities, asymmetry, or residual tissue from incomplete glandular excision affect 5–10% of patients and may require secondary revision surgery at 6–12 months when swelling has resolved. Over-resection causing chest concavity or nipple inversion is a risk of overly aggressive excision. Hypertrophic or widened periareolar scarring occurs in approximately 5%, particularly in patients with darker skin or a personal history of keloids. Recurrence of gynecomastia is possible if the causative agent (anabolic steroids, cannabis) is continued post-operatively.

An elasticated compression vest is worn continuously for 4–6 weeks to reduce swelling, support the skin flap adaptation, and optimise final chest contour. This is the single most important post-operative instruction. The drain (if placed) is removed in the first clinic appointment at 24–48 hours. Moderate bruising and swelling peak at 3–5 days and substantially resolve within 3–4 weeks. Showering is permitted after 48 hours, avoiding direct water pressure on wounds. Light activities (walking, desk work) resume at 1–2 weeks. Gym activity, swimming, and contact sports are deferred until 6 weeks. Nipple sensation changes and skin tightness improve over 3–6 months. The chest progressively flattens and contour improves as residual swelling resolves over 3–6 months — the final result is not visible until 6 months post-operatively. Scar management with silicone sheeting or gel begins at 4–6 weeks once wounds are fully healed and continues for 6 months. Sun protection of the periareolar scar for 12 months prevents hyperpigmentation. Annual skin examination and awareness of any new breast changes are recommended, as males have residual breast tissue lifelong.